This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Austen Riggs Center Board Of Trustees Announces The Appointment Of Medical Director/CEO Donald E. Rosen, M.D., Effective July 2011

STOCKBRIDGE, Mass., Sept. 28 /PRNewswire-USNewswire/ -- The Austen Riggs Center Board of Trustees announces the appointment of Donald E. Rosen, M.D., as Medical Director/CEO, effective July, 2011.  Austen Riggs' Medical Director/CEO Edward R. Shapiro, M.D., will retire on June 30, 2011 after a tenure of twenty years.



A small, not-for-profit psychiatric hospital and residential treatment center founded in 1919, the Austen Riggs Center is internationally known for its respectful and effective work with patients with significant psychiatric illness.  Consistently ranked a "Best Hospital" by U.S. News & World Report, Riggs is the only longer-term psychiatric hospital in the country that provides quality care based on intensive, individual psychodynamic psychotherapy in an open setting.  Integral to the Center's mission, Riggs' Erikson Institute for Education and Research is committed to furthering the study of psychodynamic thought and treatment.

Currently, Dr. Rosen is an Associate Professor and Director of Residency Training, Department of Psychiatry at Oregon Health Sciences University, Portland, Oregon.   Before joining OHSU in 1999, he served in many administrative and teaching positions during the 15 years he was at Menninger Clinic, then located in Topeka, Kansas, including Director of Psychiatry; Medical Director, MenningerCare Systems; Director of the Menninger Leadership Center and President of the Active Medical Staff.  He was also the Founding Director of the Professionals in Crisis Program, Director of Athletic Services, and Director of Addiction Services.

Dr. Rosen sits on the National Advisory Council for the National Health and Human Services Department Substance Abuse and Mental Health Services Administration (SAMHSA). He is also a consultant for the Oregon Impaired Physicians Program and the Oregon Attorney Assistance Program, and is Advisor to the Physicians Health Committee of Legacy Health Systems.

He is active in the American Association of Directors of Psychiatry Residency Training, serving on its executive committee as treasurer.  He is also a faculty member of the Oregon Psychoanalytic Institute.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
AAPL $124.43 0.00%
FB $82.22 0.00%
GOOG $548.00 0.00%
TSLA $188.77 0.00%
YHOO $44.44 0.00%


DOW 17,776.12 -200.19 -1.11%
S&P 500 2,067.89 -18.35 -0.88%
NASDAQ 4,900.8850 -46.5560 -0.94%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs